Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Phase 4
Recruiting
- Conditions
- Colonic DiseaseGastrointestinal DiseasesPathologic ProcessesDiseaseIrritable Bowel SyndromeIntestinal DiseaseDigestive System DiseaseColonic Diseases, Functional
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- EP Plus Group Sdn Bhd
- Target Recruit Count
- 60
- Registration Number
- NCT06271538
- Locations
- 🇲🇾
Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
News
No news found